YOLFTbeta
41

BenQ Medical Technology

4116 · TWO · Healthcare / Medical Instruments & Supplies

41.25TWD+0.45 (+1.10%)

Price History

Full chart

Market Stats

Previous Close40.80
Open41.00
Day Range40.95 – 41.95
52-Week Range35.46 – 49.90
Volume97.06K
Market Cap1.79B
P/E (TTM)15.21
Forward P/E0.00
EPS2.64
Dividend Yield4.98%
Beta0.34
50-Day Avg39.43
200-Day Avg40.13

About

BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the leasing business of medical equipment and management consulting services. It also offers electric hydraulic and manual hydraulic operating table, and operating table accessories; adjustable color temperature and single-color temperature surgical light; fixed pendant, electric pendant, and ICU suspension bridge; diagnostic display, and surgical display monitor; and portable ultrasound units, as well as it offers integrated operating system solutions. The company was formerly known as Trident Medical Corp. and changed its name to BenQ Medical Technology Corporation in June 2011. BenQ Medical Technology Corporation was incorporated in 1989 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Er-An Chu
  • Employees0
  • HeadquartersNo. 46, Zhouzi Street, Taipei, Taiwan, 11493, Taiwan
  • Websitehttps://www.benqmedicaltech.com

Leadership

  • Mr. Er-An ChuPresident, Acting Spokesperson & Representative Institutional Director
  • Zhihua LiuAccounting Supervisor

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.04B1.23B1.38B1.40B1.46B2.95B4.54B4.77B5.25B
Growth (%)-+18.91%+11.90%+1.49%+4.55%+101.51%+53.93%+4.94%+10.21%
Cost of Revenue655.20M767.45M832.43M849.22M952.31M2.09B3.20B3.32B3.56B
Gross Profit382.07M466.01M547.86M551.63M512.28M860.25M1.34B1.45B1.69B
Gross Margin36.83%37.78%39.69%39.38%34.98%29.15%29.58%30.38%32.16%
Operating Expense312.92M372.45M424.34M441.82M444.80M573.61M979.13M1.11B1.34B
Operating Income69.16M93.56M123.52M109.81M67.48M286.64M364.77M333.39M346.01M
Operating Margin6.67%7.59%8.95%7.84%4.61%9.71%8.03%6.99%6.59%
EBITDA108.73M147.86M198.34M195.40M168.53M476.65M630.26M618.82M648.33M
EBITDA Margin10.48%11.99%14.37%13.95%11.51%16.15%13.87%12.98%12.34%
Net Income46.63M66.68M75.41M62.05M28.84M180.24M114.58M104.83M78.17M
Net Income Margin4.50%5.41%5.46%4.43%1.97%6.11%2.52%2.20%1.49%
R&D46.36M38.43M44.77M44.30M39.65M39.58M31.96M36.39M34.69M
R&D as % of Total Revenue4.47%3.12%3.24%3.16%2.71%1.34%0.70%0.76%0.66%
Interest Expense03.77M4.22M4.02M3.91M13.51M27.94M34.22M44.62M
Interest Expense % of Total Revenue0.00%0.31%0.31%0.29%0.27%0.46%0.62%0.72%0.85%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.54B1.68B1.69B1.79B1.96B3.40B4.71B5.27B5.45B
Total Liabilities475.80M589.30M585.25M677.80M855.51M1.66B2.53B2.97B3.12B
Total Equity1.02B1.04B1.05B1.05B1.04B1.20B1.10B1.12B1.13B
Cash224.73M317.55M242.63M255.06M369.85M647.26M830.51M863.19M949.33M
Total Debt--240.71M303.31M491.75M852.11M---
Net Debt---1.91M48.25M121.90M204.84M405.72M671.29M718.32M

Cash Flow

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow72.97M126.10M169.23M151.48M121.35M378.77M442.35M222.22M358.75M
Investing Cash Flow-160.32M-61.09M-23.25M-104.06M-98.77M----
Financing Cash Flow66.63M28.12M-220.50M-34.99M92.15M2.43M---
Capital Expenditure112.31M31.36M21.15M42.37M32.92M60.05M139.28M175.48M99.24M
Free Cash Flow-41.26M87.67M148.09M109.12M88.42M318.72M303.07M46.74M259.51M
Dividends Paid31.02M44.57M60.16M60.16M44.57M22.28M93.59M89.13M73.53M
FCF to OCF-56.54%69.52%87.50%72.03%72.87%84.15%68.51%21.03%72.34%
Dividend Paid to FCF-75.19%50.83%40.63%55.14%50.40%6.99%30.88%190.70%28.34%

Earnings

Report DateMar 31, 2015Jun 30, 2015Dec 2, 2015Mar 2, 2016May 5, 2016Aug 16, 2016Nov 12, 2016Mar 30, 2017May 11, 2017Aug 12, 2017Nov 7, 2017Mar 22, 2018May 15, 2018Aug 13, 2018Oct 31, 2018Mar 24, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023
EPS Estimate---0.180.31----------------------------
EPS Actual0.332.710.21-0.240.220.290.190.330.140.280.240.380.110.370.370.640.450.270.440.520.180.190.320.710.110.080.190.271.960.780.770.510.51
Surprise----233.33%-29.03%----------------------------
Timing----After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-----------------

Key Statistics & Ratios

Market Cap1.79B
Enterprise Value2.72B
Trailing P/E15.21
Forward P/E0.00
Price / Sales0.33
Price / Book1.59
EPS2.64
Book Value24.74
Revenue (TTM)5.44B
Gross Profit (TTM)1.77B
EBITDA507.51M
Profit Margin2.16%
Operating Margin6.28%
Return on Equity12.95%
Return on Assets3.95%
Shares Outstanding44.57M
Shares Float21.04M
Beta0.34
Dividend Yield4.98%
Dividend Rate2.00
Payout Ratio75.85%

Dividends

20261×
2.00Jul 1, 2026
20251×
1.65Jun 30, 2025
20241×
2.00Jun 27, 2024
20231×
2.10Jun 20, 2023
20221×
0.50Jun 24, 2022
20211×
1.00Jun 28, 2021
20201×
1.35Jul 14, 2020
20191×
1.35Jul 11, 2019
20181×
1.00Jul 12, 2018
20171×
0.70Jul 12, 2017
20161×
1.50Jul 4, 2016
20151×
1.00Jul 6, 2015
20141×
0.59Jul 3, 2014
20131×
0.50Jul 2, 2013
20121×
0.50Jul 10, 2012
20111×
1.00Jul 7, 2011
20101×
0.40Sep 8, 2010
20091×
1.20Jun 29, 2009
20081×
0.80Jun 27, 2008